Related Experiment Videos
Implications of point-of-care testing for hemoglobin A1c
1Centers for Disease Control and Prevention, Atlanta, Georgia 30341-3724, USA.
Diabetes Technology & Therapeutics
|July 27, 2001
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
[The ways of harmonization of clinical laboratory measurement techniques].
Klinicheskaia laboratornaia diagnostika·2013
The national glycohemoglobin standardization program: a five-year progress report.
Clinical chemistry·2001
Current activities at the Centers for Disease Control and Prevention's National Diabetes Laboratory.
Diabetes technology & therapeutics·2001
Automated Insulin Delivery System Initiation Safely Improves Glycemic Outcomes in Older Adults with Type 1 Diabetes.
Diabetes technology & therapeutics·2026
Continuous Glucose Monitoring Metrics in Women with Type 2 Diabetes in Pregnancy: The TIMELY Observational Cohort Study.
Diabetes technology & therapeutics·2026
Three-Year Durability of Automated Insulin Delivery Therapy in Children and Adolescents with Type 1 Diabetes: A Multicenter Real-World Study.
Diabetes technology & therapeutics·2026
Evaluation of an Objective Measure of Mealtime Insulin Administration Frequency in Emerging Adults with Type 1 Diabetes.
Diabetes technology & therapeutics·2026
A Simple Meal Bolus Strategy is Effective in Adolescents and Young Adults with Type 1 Diabetes on Multiple Automated Insulin Delivery Systems.
Diabetes technology & therapeutics·2026
Use of Low-Glucose Alerts and Their Impact on Continuous Glucose Monitoring Outcomes in Real-World Use of the MiniMed 780G System.
Diabetes technology & therapeutics·2026